Forward Management, LLC Amgen Inc Transaction History

Forward Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 01, 2019	SELL	$178.4 - $208.25 $659,366 - $769,692	-3,696 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$185.29 - $208.89 $270,893 - $305,397	-1,462 Reduced 28.34%	3,696 $766,000
Q2 2018 Aug 01, 2018	SELL	$166.05 - $186.51 $8,468 - $9,512	-51 Reduced 0.98%	5,158 $952,000
Q1 2018 Apr 30, 2018	BUY	$169.43 - $198.0 $4,066 - $4,752	24 Added 0.46%	5,209 $888,000
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $19,073 - $21,310	-113 Reduced 2.13%	5,185 $901,000
Q3 2017 Nov 02, 2017	BUY	$167.29 - $191.0 $886,302 - $1.01 Million	5,298	5,298 $987,000

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Forward Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Forward Management, LLC with notifications on news.